Abstract

To achieve good metabolic control in diabetes and keep long term, a combination of changes in lifestyle and pharmacological treatment is necessary. Achieving near-normal glycated hemoglobin significantly, decreases risk of macrovascular and microvascular complications. At present there are different treatments, both oral and injectable, available for the treatment of type 2 diabetes mellitus (T2DM). Treatment algorithms designed to reduce the development or progression of the complications of diabetes emphasizes the need for good glycaemic control. The aim of this review is to perform an update on the benefits and limitations of different drugs, both current and future, for the treatment of T2DM. Initial…

Citation impact

653
total citations
FWCI
24.80
Percentile
100%
References
396
Citations per year

Authors

4

Topics & keywords

Keywords
  • Medicine
  • Metformin
  • Glycated hemoglobin
  • Type 2 Diabetes Mellitus
  • Diabetes mellitus
  • Intensive care medicine
  • Type 2 diabetes
  • Metabolic control analysis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.